Buy ONCASPAR 750U/ml Pegaspargase

ONCASPAR 750U/ml is an injectable medication containing pegaspargase, designed for use in chemotherapy regimens. It is supplied as vials with a strength of 3750 IU. This product is manufactured in Switzerland and is used under medical supervision.

Strength

3750 IE

Manufacturer / TM Owner

SERVIER (SUISSE) SA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Pegaspargase is used in combination with other chemotherapy drugs to treat acute lymphoblastic leukemia (ALL). It works by reducing the levels of asparagine in the blood, which helps slow the growth of cancer cells. This medication is typically part of a broader treatment plan for certain blood cancers. It is not used for general pain relief or infections.

Side Effects

Pegaspargase helps reduce cancer cell growth by depleting asparagine, an amino acid necessary for cell survival. Patients may experience effects such as fatigue or nausea during treatment. These effects vary and should be monitored by a healthcare provider. Regular blood tests are often required to assess response and safety.

Precautions & Warnings

This medication should only be administered by healthcare professionals in a clinical setting. Patients with a history of pancreatitis, blood clotting disorders, or liver problems should inform their doctor before use. Pregnant or breastfeeding individuals should discuss risks with their healthcare provider. Proper storage and handling are essential to maintain product integrity.

Avoid Interactions

Pegaspargase may interact with other medications, including blood thinners, immunosuppressants, and certain vaccines. Alcohol and herbal supplements should be avoided unless approved by a doctor. Live vaccines may have reduced effectiveness during treatment. Always inform your healthcare provider about all medications and supplements you are taking.

References

Frequently Asked Questions

Pegaspargase is primarily used in chemotherapy to treat acute lymphoblastic leukemia (ALL) as part of a combination regimen.

ONCASPAR is administered by injection, typically in a hospital or clinic setting under medical supervision.

Common effects may include nausea, fatigue, or changes in blood test results, which should be monitored by a healthcare provider.

Pregnant individuals should discuss potential risks with their doctor before using this medication.

No, pegaspargase is a prescription medication and must be administered by a healthcare professional.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.